Lotechek Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation following ocular surgery, and anterior uveitis. Loteprednol etabonate is a synthetic corticosteroid with potent anti-inflammatory properties that act by inhibiting the release of inflammatory mediators and suppressing the immune response in ocular tissues. This medication helps reduce redness, swelling, and discomfort associated with ocular inflammation. Lotechek Eye Drop is administered topically, allowing targeted delivery to the affected area, minimizing systemic absorption and associated side effects. It is typically prescribed for short-term use under the supervision of an ophthalmologist, with dosage tailored according to the severity of the condition. Patients should avoid contact lens use during treatment unless otherwise directed by a healthcare professional. Common adverse effects may include mild burning or stinging upon instillation, increased intraocular pressure, and, rarely, secondary infections. Prolonged use may increase the risk of cataract formation or glaucoma; therefore, regular monitoring of intraocular pressure is recommended. Lotechek Eye Drop should be used cautiously in patients with a history of ocular infections, glaucoma, or hypersensitivity to corticosteroids.